WHO: 2nd COVID booster for most vulnerable offers benefits

An expert group convened by the World Health Organization says there may be some benefit to giving a second booster dose of coronavirus vaccine to the most vulnerable people amid the continuing global spread of omicron and its subvariants

Via AP news wire
Tuesday 17 May 2022 19:28
WHO COVID 2nd Booster
WHO COVID 2nd Booster

An expert group convened by the World Health Organization says there may be some benefit in giving a second booster dose of coronavirus vaccine to the most vulnerable people amid the continuing global spread of omicron and its subvariants.

In a statement issued on Tuesday, the United Nations health agency said there was “a growing body of evidence regarding the value of an additional booster dose” for groups including health workers, people aged over 60 and those with weak immune systems.

The WHO said its expert group had assessed the limited data from seven studies for second booster doses of messenger RNA vaccines, saying there wasn't enough information proving their effectiveness in younger, healthy people.

“In those most at risk for severe disease or death ... the additional benefit of an additional booster dose of mRNA vaccine might be warranted,” the WHO said, acknowledging that there could be logistical or other challenges to offering people a second booster dose in some countries. While many rich countries have vaccinated more than 70% of their populations, fewer than 16% of people in poorer countries have been immunized.

Last year, the WHO repeatedly criticized rich countries for offering booster doses and called for a moratorium on the practice, saying boosters were unnecessary for healthy people. The agency reversed its advice late last year amid the spread of the hugely infectious omicron variant, after dozens of countries began offering booster doses.

Some health experts have warned that countries embarking on additional booster campaigns could deplete the world's supply of COVID-19 vaccines before the most vulnerable people in developing countries have been offered a single shot.

The U.S. Food and Drug Administration recommended in March that Americans 50 and over be eligible for a second COVID-19 booster shot while the European Medicines Agency has only cleared second booster doses for those 80 and over.

Amid the continuing spread of omicron and its subvariants, the WHO and others have continued to call for accelerated vaccination campaigns.

“What we are seeing is that people who are vaccinated have a much reduced risk of developing severe disease and death,” said WHO's COVID-19 lead Maria Van Kerkhove, warning against the false perception that omicron is mild. “We have solutions for this because we have vaccines," she said.

___

Follow AP’s coverage of the pandemic at https://apnews.com/hub/coronavirus-pandemic

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in